These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37610353)

  • 1. MULGA, a unified multi-view graph autoencoder-based approach for identifying drug-protein interaction and drug repositioning.
    Ma J; Li C; Zhang Y; Wang Z; Li S; Guo Y; Zhang L; Liu H; Gao X; Song J
    Bioinformatics; 2023 Sep; 39(9):. PubMed ID: 37610353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NerLTR-DTA: drug-target binding affinity prediction based on neighbor relationship and learning to rank.
    Ru X; Ye X; Sakurai T; Zou Q
    Bioinformatics; 2022 Mar; 38(7):1964-1971. PubMed ID: 35134828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MultiDTI: drug-target interaction prediction based on multi-modal representation learning to bridge the gap between new chemical entities and known heterogeneous network.
    Zhou D; Xu Z; Li W; Xie X; Peng S
    Bioinformatics; 2021 Dec; 37(23):4485-4492. PubMed ID: 34180970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
    Jarada TN; Rokne JG; Alhajj R
    BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational drug repositioning based on multi-similarities bilinear matrix factorization.
    Yang M; Wu G; Zhao Q; Li Y; Wang J
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33147616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-target interaction predictions with multi-view similarity network fusion strategy and deep interactive attention mechanism.
    Song W; Xu L; Han C; Tian Z; Zou Q
    Bioinformatics; 2024 Jun; 40(6):. PubMed ID: 38837345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. deepDR: a network-based deep learning approach to in silico drug repositioning.
    Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
    Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VGAEDTI: drug-target interaction prediction based on variational inference and graph autoencoder.
    Zhang Y; Feng Y; Wu M; Deng Z; Wang S
    BMC Bioinformatics; 2023 Jul; 24(1):278. PubMed ID: 37415176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repositioning based on multi-view learning with matrix completion.
    Yan Y; Yang M; Zhao H; Duan G; Peng X; Wang J
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35289352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repositioning based on the heterogeneous information fusion graph convolutional network.
    Cai L; Lu C; Xu J; Meng Y; Wang P; Fu X; Zeng X; Su Y
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34378011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-task prediction-based graph contrastive learning for inferring the relationship among lncRNAs, miRNAs and diseases.
    Sheng N; Wang Y; Huang L; Gao L; Cao Y; Xie X; Fu Y
    Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37529914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-supervised heterogeneous graph contrastive learning for drug-target interaction prediction.
    Yao K; Wang X; Li W; Zhu H; Jiang Y; Li Y; Tian T; Yang Z; Liu Q; Liu Q
    Comput Biol Med; 2023 Sep; 163():107199. PubMed ID: 37421738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Computational Drug-Repositioning by Self-Paced Non-Negative Matrix Tri-Factorization.
    Dang Q; Liang Y; Ouyang D; Miao R; Ling C; Liu X; Xie S
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(3):1953-1962. PubMed ID: 36445996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network.
    Sun X; Wang B; Zhang J; Li M
    IEEE J Biomed Health Inform; 2022 Nov; 26(11):5757-5765. PubMed ID: 35921345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Drug-Protein Interactions by Self-Adaptively Adjusting the Topological Structure of the Heterogeneous Network.
    Tang R; Sun C; Huang J; Li M; Wei J; Liu J
    IEEE J Biomed Health Inform; 2023 Nov; 27(11):5675-5684. PubMed ID: 37672364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDPI: adaptively learning importance of multi-scale topologies and multi-modality similarities for drug-protein interaction prediction.
    Hu K; Cui H; Zhang T; Sun C; Xuan P
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35108362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous graph inference with matrix completion for computational drug repositioning.
    Yang M; Huang L; Xu Y; Lu C; Wang J
    Bioinformatics; 2021 Apr; 36(22-23):5456-5464. PubMed ID: 33331887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug-Target Binding Affinity Prediction.
    Wang S; Song X; Zhang Y; Zhang K; Liu Y; Ren C; Pang S
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved drug-target interaction prediction with intermolecular graph transformer.
    Liu S; Wang Y; Deng Y; He L; Shao B; Yin J; Zheng N; Liu TY; Wang T
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.